Author + information
- Received July 6, 1993
- Revision received September 7, 1994
- Accepted November 1, 1994
- Published online March 15, 1995.
- Edward A. Gill, MD*,
- Clarisa Borrego, MD,
- Bruce E. Bray, MD, FACC,
- Dale G. Renlund, MD, FACC,
- Elizabeth H. Hammond, MD and
- Edward M. Gilbert, MD, FACC
- ↵*Dr. Edward M. Gilbert, Division of Cardiology 4A-100, University of Utah Medical Center, 50 North Medical Drive, Salt Lake City, Utah 84132.
Objectives. This study evaluated whether left ventricular mass increases during cellular or vascular (humoral) cardiac allograft rejection.
Background. An increase in left ventricular mass during cellular cardiac allograft rejection has been described by other investigators, although controversy has existed over the validity of these findings. Left ventricular mass changes have not been evaluated in the setting of vascular (humoral) cardiac allograft rejection.
Methods. To determine the effect of allograft rejection on left ventricular mass, we retrospectively reviewed endomyocardial biopsy results and corresponding echocardiograms in 41 cardiac transplant recipients undergoing treatment for allograft rejection. Left ventricular mass was assessed by two-dimensional echocardiography using the method of Schiller. Maintenance immunosuppression included cyclosporine in all patients.
Results. Although significant changes in left ventricular wall thickness, mass and dimensions were not observed in patients experiencing moderate or severe cellular allograft rejection (International Society for Heart and Lung Transplantation grades III and IV, n = 27), marked changes were noted in patients with vascular (humoral) rejection (n = 14). Patients with vascular rejection demonstrated an echocardiographic mean (±SEM) increase in left ventricular wall mass (from 109 ± 17 to 151 ± 17g), and left ventricular wall thickness (from 1.3 ± 0.1 to 1.6 ± 0.1cm) during the rejection episode. Additionally, vascular rejection was associated with a trend toward an increase in left ventricular systolic dimension (from 2.6 ± 0.1 to 3.0 ± 0.2 cm) and a decrease in left ventricular fractional shortening and increased incidence of hemodynamic compromise with rejection (50% for vascular vs. 11% for cellular rejection).
Conclusions. Left ventricular mass increases during episodes of vascular (humoral) rejection, but there is no significant change in left ventricular mass during cellular cardiac allograft rejection.
- Received July 6, 1993.
- Revision received September 7, 1994.
- Accepted November 1, 1994.
- American College of Cardiology